Hybridization and footprinting methods to characterize the interactions of 16s rrna analogues for identification of novel antibiotics
CA 2198261 C · Owner: University Of Massachusetts Medical Center · Inventors: Stern, Seth; Purohit, Prakash
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The oligoribonucleotide analogs of the invention as exemplified in the , figure, are relatively small three-dimensional structures derived from larger parental RNA molecules. The analogs include a first nucleic acid structure including one or more nucleotide sequences that are derived from a region of parental RNA, wherein in its native state the region binds to a ligand, e.g. an aminoglycoside with a parental RNA ligand binding pattern and a second , nucleic acid structure including one or more nucleotide sequences combined with the first nucleic acid structure to form the analog and provide the analog with a conformation that binds the ligand with a ligand binding pattern that is …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 23, 1995 and granted October 28, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 23, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 23, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.